Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...
Novartis is on the final straight to approval of its spinal muscular atrophy (SMA) gene therapy Zolgensma in the EU, after getting a recommendation for approval from the CHMP. The positive opinion ...
KYOCERA AVX has expanded its TransGuard® VT Series with new automotive-grade multilayer varistors for 48 V power supply systems, designed for transient voltage suppression and EMI/RFI attenuation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results